Cargando…

‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism

OBJECTIVE: We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients. DESIGN: A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Nainani, Abhir Krishan, Yang, Jun, Peters, Sanne, Russell, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196168/
https://www.ncbi.nlm.nih.gov/pubmed/35697463
http://dx.doi.org/10.1136/bmjopen-2022-061671
_version_ 1784727123561283584
author Nainani, Abhir Krishan
Yang, Jun
Peters, Sanne
Russell, Grant
author_facet Nainani, Abhir Krishan
Yang, Jun
Peters, Sanne
Russell, Grant
author_sort Nainani, Abhir Krishan
collection PubMed
description OBJECTIVE: We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients. DESIGN: A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed verbatim, entered into NVivo V.12.0 for coding and analysed for emerging themes. SETTING: Melbourne, Australia. PARTICIPANTS: Eligible GPs had received education on PA as part of a previous study. We recruited a purposive sample of 16 GPs (6 females, 10 males) who varied in practice location, clinical experience and the number of patients screened for PA. RESULTS: Although GPs had been educated about PA, they found it challenging to explain the condition to patients and were uncertain about how to screen patients who were already taking antihypertensive medications. Most viewed the screening process to be practical, inexpensive and, by and large, acceptable to their patients. However, they found it inconvenient to alter antihypertensive medications before screening to allow for easier interpretation of the aldosterone-renin ratio. They were also less enthused about screening patients whom they thought fitted a clinical picture of essential hypertension. Knowledge of the screening process, cost and convenience of performing the aldosterone–renin ratio, conceptualisation of risk related to PA, and a desire to improve clinical care were influencing factors that modified the GPs’ screening experience. CONCLUSION: Our findings suggest that knowledge gaps, practical limitations of the aldosterone–renin ratio, and errors in diagnostic reasoning were challenges of routine PA screening. Most of these practical barriers could be addressed by relatively simple educational and practice modifications to increase PA screening rates and optimise detection for the most common cause of secondary hypertension in primary care.
format Online
Article
Text
id pubmed-9196168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-91961682022-07-08 ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism Nainani, Abhir Krishan Yang, Jun Peters, Sanne Russell, Grant BMJ Open General practice / Family practice OBJECTIVE: We sought to understand the factors that influence a general practitioner’s (GP’s) experience of screening for primary aldosteronism (PA) in hypertensive patients. DESIGN: A qualitative study, framed by phenomenology, using semistructured interviews that were audiorecorded, transcribed verbatim, entered into NVivo V.12.0 for coding and analysed for emerging themes. SETTING: Melbourne, Australia. PARTICIPANTS: Eligible GPs had received education on PA as part of a previous study. We recruited a purposive sample of 16 GPs (6 females, 10 males) who varied in practice location, clinical experience and the number of patients screened for PA. RESULTS: Although GPs had been educated about PA, they found it challenging to explain the condition to patients and were uncertain about how to screen patients who were already taking antihypertensive medications. Most viewed the screening process to be practical, inexpensive and, by and large, acceptable to their patients. However, they found it inconvenient to alter antihypertensive medications before screening to allow for easier interpretation of the aldosterone-renin ratio. They were also less enthused about screening patients whom they thought fitted a clinical picture of essential hypertension. Knowledge of the screening process, cost and convenience of performing the aldosterone–renin ratio, conceptualisation of risk related to PA, and a desire to improve clinical care were influencing factors that modified the GPs’ screening experience. CONCLUSION: Our findings suggest that knowledge gaps, practical limitations of the aldosterone–renin ratio, and errors in diagnostic reasoning were challenges of routine PA screening. Most of these practical barriers could be addressed by relatively simple educational and practice modifications to increase PA screening rates and optimise detection for the most common cause of secondary hypertension in primary care. BMJ Publishing Group 2022-06-12 /pmc/articles/PMC9196168/ /pubmed/35697463 http://dx.doi.org/10.1136/bmjopen-2022-061671 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle General practice / Family practice
Nainani, Abhir Krishan
Yang, Jun
Peters, Sanne
Russell, Grant
‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_full ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_fullStr ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_full_unstemmed ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_short ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
title_sort ‘i can’t understand why others don’t screen more’: a qualitative study exploring why australian general practitioners screen for primary aldosteronism
topic General practice / Family practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196168/
https://www.ncbi.nlm.nih.gov/pubmed/35697463
http://dx.doi.org/10.1136/bmjopen-2022-061671
work_keys_str_mv AT nainaniabhirkrishan icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT yangjun icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT peterssanne icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism
AT russellgrant icantunderstandwhyothersdontscreenmoreaqualitativestudyexploringwhyaustraliangeneralpractitionersscreenforprimaryaldosteronism